Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proceedings of the 2023 Second Annual ASTCT-NMDP ACCESS Initiative Workshop.
Auletta JJ, Holter-Chakrabarty J, Jain T, Miller B, Ward E, Khera N, Gomez-Arteaga A, Hall A, Nemecek E, Robb D, Yusuf RA, Davies SM; ACCESS Workshop Team Members. Auletta JJ, et al. Among authors: gomez arteaga a. Transplant Cell Ther. 2023 Dec;29(12):739-746. doi: 10.1016/j.jtct.2023.09.026. Epub 2023 Oct 5. Transplant Cell Ther. 2023. PMID: 37805142
Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients.
Patel C, Pasciolla M, Abramova R, Salerno D, Gomez-Arteaga A, Shore TB, Orfali N, Mayer S, Hsu J, Phillips AA, Chaekal OK, Satlin MJ, Soave R, Kodiyanplakkal RPL, Drelick A, Plate M, Besien KV. Patel C, et al. Among authors: gomez arteaga a. Transplant Cell Ther. 2023 Feb;29(2):132.e1-132.e5. doi: 10.1016/j.jtct.2022.10.023. Epub 2022 Nov 9. Transplant Cell Ther. 2023. PMID: 36334653 Free article.
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation.
Chaekal OK, Gomez-Arteaga A, Chen Z, Soave R, Shore T, Mayer S, Phillips A, Hsu JM, Drelick A, Kodiyanplakkal RPL, Plate M, Satlin MJ, van Besien K. Chaekal OK, et al. Among authors: gomez arteaga a. Transplant Cell Ther. 2022 Sep;28(9):618.e1-618.e10. doi: 10.1016/j.jtct.2022.06.012. Epub 2022 Jun 18. Transplant Cell Ther. 2022. PMID: 35724850 Free PMC article.
Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation.
Alhomoud M, Chokr N, Gomez-Arteaga A, Chen Z, Escalon JG, Legasto AC, Brusca-Augello G, Yamshon S, Plate M, Zappetti D, Hsu JM, Phillips A, Mayer S, Shore T, Van Besien K. Alhomoud M, et al. Among authors: gomez arteaga a. Transplant Cell Ther. 2023 May;29(5):326.e1-326.e10. doi: 10.1016/j.jtct.2023.01.029. Epub 2023 Feb 3. Transplant Cell Ther. 2023. PMID: 36739088 Free article.
Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a case series.
Gomez-Arteaga A, Scordo M, Tamari R, Ruiz JD, Jakubowski AA, Papadopoulos EB, Giralt SA, Perales MA, Castro-Malaspina HR, Sauter CS, Dahi PB. Gomez-Arteaga A, et al. Bone Marrow Transplant. 2020 Dec;55(12):2326-2330. doi: 10.1038/s41409-020-0939-9. Epub 2020 May 18. Bone Marrow Transplant. 2020. PMID: 32424188 No abstract available.
Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation.
Alhomoud M, Magro C, Seshan S, Zhang T, Gomez-Arteaga A, Chokr N, Yamshon S, Phillips A, Mayer S, Shore T, Laurence J. Alhomoud M, et al. Among authors: gomez arteaga a. Bone Marrow Transplant. 2023 Nov;58(11):1270-1274. doi: 10.1038/s41409-023-02089-y. Epub 2023 Aug 21. Bone Marrow Transplant. 2023. PMID: 37604872 No abstract available.
Prognostic Factors for Postrelapse Survival after ex Vivo CD34+-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma.
Gomez-Arteaga A, Shah GL, Baser RE, Scordo M, Ruiz JD, Bryant A, Dahi PB, Ghosh A, Lahoud OB, Landau HJ, Landgren O, Shaffer BC, Smith EL, Koehne G, Perales MA, Giralt SA, Chung DJ. Gomez-Arteaga A, et al. Biol Blood Marrow Transplant. 2020 Nov;26(11):2040-2046. doi: 10.1016/j.bbmt.2020.07.016. Epub 2020 Jul 23. Biol Blood Marrow Transplant. 2020. PMID: 32712326 Free PMC article.
Cord blood transplants supported by unrelated donor CD34+ progenitor cells.
Gomez-Arteaga A, Orfali N, Guarneri D, Cushing MM, Gergis U, Hsu J, Hsu YS, Mayer SA, Phillips AA, Chase SA, Mokhtar AE, Shore TB, Van Besien K. Gomez-Arteaga A, et al. Bone Marrow Transplant. 2020 Dec;55(12):2298-2307. doi: 10.1038/s41409-020-0959-5. Epub 2020 Jun 9. Bone Marrow Transplant. 2020. PMID: 32518291
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.
Menghrajani K, Gomez-Arteaga A, Madero-Marroquin R, Zhang MJ, Bo-Subait K, Sanchez J, Wang HL, Aljurf M, Assal A, Bacher VU, Badawy SM, Bejanyan N, Bhatt VR, Bredeson C, Byrne M, Castillo P, Cerny J, Chhabra S, Ciurea SO, DeFilipp Z, Farhadfar N, Gadalla S, Gale RP, Ganguly S, Gowda L, Grunwald MR, Hashmi S, Hildebrandt G, Kanakry CG, Kansagra A, Khimani F, Krem M, Lazarus H, Liu H, Martino R, Michelis FV, Nathan S, Nishihori T, Olsson R, Reshef R, Rizzieri D, Rowe JM, Savani BN, Seo S, Sharma A, Solh M, Ustun C, Verdonck LF, Hourigan C, Sandmaier B, Litzow M, Kebriaei P, Weisdorf D, Zhang Y, Tallman MS, Saber W. Menghrajani K, et al. Blood Adv. 2022 Jan 8;6(3):828-847. doi: 10.1182/bloodadvances.2021004881. Blood Adv. 2022. PMID: 34551064 Free PMC article.
24 results